Canterbury DHB


Management of B-CLL

Indications for Treatment

Treatment is indicated for the following:

The following on their own are NOT indications for treatment:

Asymptomatic Patients

Asymptomatic, elderly patients may be managed in primary care provided clear instructions for referral are provided. If the patient is referred to the GP, give recommendations for monitoring and re-referral to both the GP and the patient.

Young Patients

Young patients, often taken as <55 years, have a better prognosis than older patients with median survival of 12.5 years, but nevertheless will have considerably shorter life expectancy than age-matched peers. Aggressive treatment with a view to allografting may be appropriate for younger patients and should be discussed early in management.

See Delgado, J. and N. Villamor (2014). "Chronic lymphocytic leukemia in young individuals revisited." Haematologica 99(1): 4-5 and Parikh, S. A., et al. (2014). "Chronic lymphocytic leukemia in young (≤55 years) patients: a comprehensive analysis of prognostic factors and outcomes." Haematologica 99(1): 140-147.

Current Trials in CLL

For current trials in CLL, see the Clinical Trials page on the Intranet or phone the Clinical Trials Co-ordinator (ext: 80377).

In This Section

Treatment of Newly-Diagnosed Non-trial Patients

Management of Early Stage B-CLL - Information for general practitioners

About this Canterbury DHB document (5508):

Document Owner:

Blake Hsu (see Who's Who)

Last Reviewed:

September 2018

Next Review:

September 2021


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5508